SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001326389-24-000080
Filing Date
2024-02-12
Accepted
2024-02-12 12:51:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONDUIT PHARMACEUTICALS INC. MurphyCanyonAcquisitionCorp.txt SC 13G/A 5672
  Complete submission text file 0001326389-24-000080.txt   7452
Mailing Address 16 YORK STREET SUITE 2900 TORONTO A6 M5J 0E6
Business Address 16 YORK STREET SUITE 2900 TORONTO A6 M5J 0E6 416-367-4364
Polar Asset Management Partners Inc. (Filed by) CIK: 0001326389 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Subject) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93313 | Film No.: 24618702
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)